These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 3085299)

  • 1. Skin allograft rejection by L3/T4+ and Lyt-2+ T cell subsets.
    Cobbold S; Waldmann H
    Transplantation; 1986 May; 41(5):634-9. PubMed ID: 3085299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of T4+ and Ly-2+ cells in skin graft rejection in the mouse.
    Wheelahan J; McKenzie IF
    Transplantation; 1987 Aug; 44(2):273-80. PubMed ID: 3114924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional analysis of T lymphocyte subsets in antiviral host defense.
    Leist TP; Cobbold SP; Waldmann H; Aguet M; Zinkernagel RM
    J Immunol; 1987 Apr; 138(7):2278-81. PubMed ID: 2435794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
    Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M
    J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotype, specificity, and function of T cell subsets and T cell interactions involved in skin allograft rejection.
    Rosenberg AS; Mizuochi T; Sharrow SO; Singer A
    J Exp Med; 1987 May; 165(5):1296-315. PubMed ID: 2437237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A reexamination of the role of LYT-2-positive T cells in murine skin graft rejection.
    LeFrancois L; Bevan MJ
    J Exp Med; 1984 Jan; 159(1):57-67. PubMed ID: 6198428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired resistance to Mycobacterium tuberculosis infection after selective in vivo depletion of L3T4+ and Lyt-2+ T cells.
    Müller I; Cobbold SP; Waldmann H; Kaufmann SH
    Infect Immun; 1987 Sep; 55(9):2037-41. PubMed ID: 3114143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functions of purified L3T4+ and Lyt-2+ cells in vitro and in vivo.
    Sprent J; Schaefer M; Lo D; Korngold R
    Immunol Rev; 1986 Jun; 91():195-218. PubMed ID: 2942460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of Lyt-2+ T-cells in the resistance of melphalan-cured MOPC-315 tumor bearers to a challenge with MOPC-315 tumor cells.
    Barker E; Mokyr MB
    Cancer Res; 1988 Sep; 48(17):4834-42. PubMed ID: 3261626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular basis of skin allograft rejection across a class I major histocompatibility barrier in mice depleted of CD8+ T cells in vivo.
    Rosenberg AS; Munitz TI; Maniero TG; Singer A
    J Exp Med; 1991 Jun; 173(6):1463-71. PubMed ID: 1674524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rejection of skin grafts and generation of cytotoxic T cells by mice depleted of L3T4+ cells.
    Woodcock J; Wofsy D; Eriksson E; Scott JH; Seaman WE
    Transplantation; 1986 Dec; 42(6):636-42. PubMed ID: 2947360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rejection of cultured thyroid allografts by the transfer of sensitized LYT 2+ T cells.
    Warren HS; Pembrey RG
    Transplantation; 1986 Apr; 41(4):421-6. PubMed ID: 3083539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship among function, phenotype, and specificity in primary allospecific T cell populations: identification of phenotypically identical but functionally distinct primary T cell subsets that differ in their recognition of MHC class I and class II allodeterminants.
    Golding H; Mizuochi T; McCarthy SA; Cleveland CA; Singer A
    J Immunol; 1987 Jan; 138(1):10-7. PubMed ID: 2946773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of anti-L3T4 and anti-Lyt 2 monoclonal antibodies on murine cardiac allograft rejection.
    Madsen JC; Wood KJ; Morris PJ
    Transplant Proc; 1987 Oct; 19(5):3991-2. PubMed ID: 3313979
    [No Abstract]   [Full Text] [Related]  

  • 15. T cell subsets in the immune rejection of murine heterotopic corneal allografts.
    Matoba AY; Peeler JS; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1244-54. PubMed ID: 2942516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cells mediating graft rejection in the mouse. I. Lyt-1 cells mediate skin graft rejection.
    Loveland BE; Hogarth PM; Ceredig R; McKenzie IF
    J Exp Med; 1981 May; 153(5):1044-57. PubMed ID: 7019377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alloresistance to engraftment of allogeneic donor bone marrow is mediated by an Lyt-2+ T cell in mixed allogeneic reconstitution (C57BL/10Sn + B10.D2/nSn----C57BL/10Sn).
    Ildstad ST; Bluestone JA; Sachs DH
    J Exp Med; 1986 May; 163(5):1343-8. PubMed ID: 2939173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of dexamethasone treatment on the lymphoid and stromal composition of the mouse thymus: a flowcytometric and immunohistological analysis.
    van Vliet E; Melis M; van Ewijk W
    Cell Immunol; 1986 Dec; 103(2):229-40. PubMed ID: 2879639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell subsets in allograft rejection. In situ characterization of T cell subsets in human skin allografts by the use of monoclonal antibodies.
    Bhan AK; Mihm MC; Dvorak HF
    J Immunol; 1982 Oct; 129(4):1578-83. PubMed ID: 6213716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular pathways for rejection of class-I-MHC--disparate skin and tumor allografts.
    Smith DM; Stuart FP; Wemhoff GA; Quintáns J; Fitch FW
    Transplantation; 1988 Jan; 45(1):168-75. PubMed ID: 3276046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.